Aqilion hires Martin Johansson as medicinal chemistry expert

Martin Johansson holds a doctorate in organic chemistry from Lund University, Sweden, where he is currently an Associate Professor at the Center for Analysis and Synthesis. He has almost 20 years’ experience of medicinal chemistry and commercial drug discovery. Martin has previously held positions as senior researcher in AstraZeneca’s organization for Discovery R&D, in Södertälje, […]

16 October 2019: EARLY CLINICAL DEVELOPMENT at World Trade Center in Stockholm

Aqilion’s CEO Sarah Fredriksson is giving a presentation on the topic of finding new interesting projects. EARLY CLINICAL DEVELOPMENT on the 16th of October 2019 at World Trade Center in Stockholm Early_clinical_program.pdf